GAL and carcinoma: In this regard, α5β1 integrin expression, inhibition of Ras-MEK-ERK signaling pathway, and accumulation of cyclin-dependent kinase inhibitors p21 and p27 mediated GAL-1-carcinoma cell growth inhibition (232).